Lu, P-L.
~ 100  Ergebnisse:
Personensuche X
?
1

Probing the influence maximization-cost minimization proble..:

, In: Proceedings of the 2023 4th International Conference on Computing, Networks and Internet of Things,
Tang, Jx ; Zhang, L ; Lu, Pl. - p. 600-606 , 2023
 
?
2

Active surveillance for suspected COVID-19 cases in inpatie..:

Lin, C-Y. ; Cheng, C-H. ; Lu, P-L....
Journal of Hospital Infection.  105 (2020)  2 - p. 197-199 , 2020
 
?
3

Do stampers cross-transmit bacteria when used on human skin..:

Chen, C-H. ; Chen, Y-J. ; Jao, Y-T....
Journal of Hospital Infection.  106 (2020)  3 - p. 631-632 , 2020
 
?
4

First report of OXA-48 carbapenemase-producing Escherichia ..:

Jao, Y ; Lee, P-S ; Hung, C-T...
Antimicrobial Resistance and Infection Control.  4 (2015)  S1 - p. , 2015
 
?
5

Free-flow duration prior as an influential factor on microo..:

Jao, Y ; Wu, SW ; Lin, TY...
Antimicrobial Resistance and Infection Control.  4 (2015)  S1 - p. , 2015
 
?
7

Resistance mechanisms and molecular epidemiology of carbape..:

Chang YT ; Siu LK ; Wang JT...
https://www.dovepress.com/resistance-mechanisms-and-molecular-epidemiology-of-carbapenem-nonsusc-peer-reviewed-article-IDR.  , 2019
 
?
8

In vitro activity of ceftazidime–avibactam, ceftolozane–taz..:

Jean SS ; Lu MC ; Shi ZY...
https://www.dovepress.com/in-vitro-activity-of-ceftazidimendashavibactam-ceftolozanendashtazobac-peer-reviewed-article-IDR.  , 2018
 
?
10

First report of OXA-48 carbapenemase-producing Escherichia ..:

Jao, Y ; Lee, P-S ; Hung, C-T...
http://www.aricjournal.com/content/4/S1/P126.  , 2015
 
?
11

Free-flow duration prior as an influential factor on microo..:

Jao, Y ; Wu, SW ; Lin, TY...
http://www.aricjournal.com/content/4/S1/P65.  , 2015
 
?
13

Effectiveness of pharmaceutical strategies for pandemic H1N..:

Wu, U-I ; Hu, F-C ; Chang, S-C...
http://www.biomedcentral.com/1753-6561/5/S6/P88.  , 2011
 
?
14

O-229 Neck scarf of ureter and Intraoperative ICG-fluoresce..:

Chuang, YC ; Lu, HF ; Chen, SU..
Human Reproduction.  39 (2024)  Supplement_1 - p. , 2024
 
?
15

145P An engineered ligand-trap biologic targeting the CD47 ..:

Juo, Z.S. ; Wang, J-T. ; Tseng, C-L....
Immuno-Oncology and Technology.  20 (2023)  - p. 100617 , 2023
 
1-15